Keywords: |
leukemia; major clinical study; review; paclitaxel; cancer radiotherapy; methotrexate; neoplasms; t lymphocyte; lung toxicity; multiple myeloma; lung disease; lung neoplasms; cyclophosphamide; cancer therapy; carmustine; hodgkin disease; b lymphocyte; docetaxel; pneumonia; thromboembolism; eflornithine; bleomycin; bronchoscopy; pleura effusion; virus infection; vinca alkaloid; immune deficiency; corticosteroid; mitomycin; immunosuppressive treatment; lung infection; bacterial infections; lung aspergillosis; tuberculosis; granulocyte; bronchospasm; lung hemorrhage; lung diseases; bronchiolitis; bacterial pneumonia; lung edema; trimetrexate; respiratory system; obstructive airway disease; amphotericin b; cryptococcus; lung diseases, fungal; cancer; humans; human; priority journal; open lung biopsy; cotrifamole; lung diseases, parasitic
|